{"slideshow_credits": null, "snippet": "The deal would further bolster Jazz\u2019s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY", "contributor": ""}, "web_url": "http://www.nytimes.com/2016/06/01/business/dealbook/jazz-pharmaceuticals-buy-celator-leukemia.html", "lead_paragraph": "The deal would further bolster Jazz\u2019s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.", "headline": {"main": "Jazz Pharmaceuticals to Buy Celator for $1.5 Billion"}, "_id": "574d588738f0d826276782e3", "word_count": "454", "multimedia": [], "pub_date": "2016-06-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Jazz Pharmaceuticals Inc", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}